Yi-Hsuan Huang

5PUBLICATIONS
9CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Infant and child healthChemotherapyEpidemiological modelling
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jan 12, 2026
Tramadol induced hypoxia signaling and paraptosis-like cell death in breast cancer cells via HIF-1α and ATF4 dependent pathways.

Zih-Syuan Wu, Shih-Ming Huang, Yi-Hsuan Huang

|May 14, 2025
O-Desmethyltramadol Enhanced Anti-Cancer Efficacy over Tramadol Through Non-μ-Opioid Receptor and Differential Cellular Contexts of Human Breast Cancer Cells.

Zih-Syuan Wu, Yi-Hsuan Huang, Shih-Ming Huang

|Feb 11, 2023
Comparison of Single Target-Controlled Infusion Pump-Delivered Mixed Propofol and Remifentanil with Two Target-Controlled Infusion Pumps-Delivered Propofol and Remifentanil in Patients Undergoing Breast Cancer Surgery-A Prospective Study.

Hou-Chuan Lai, Meng-Fu Lai, Yi-Hsuan Huang

|Jan 08, 2023
Mitochondrial Dysfunction Involved in the Cytotoxicity of Tramadol in Human Endometrial Carcinoma Cells.

Li-Chun Liu, Zih-Syuan Wu, Jia-Lin Chen

|Sep 10, 2021
Postoperative Drip-Infusion of Remifentanil Reduces Postoperative Pain-A Retrospective Observative Study.

Yi-Hsuan Huang, Meei-Shyuan Lee, Yao-Tsung Lin

Pageof 1

Frequent Collaborators

3 joint publications

Zhi-Fu Wu

2 joint publications

Zih-Syuan Wu

2 joint publications

Hou-Chuan Lai

2 joint publications

Shih-Ming Huang